Your browser doesn't support javascript.
loading
Evaluation of the impact of patient involvement in health technology assessments: A scoping review.
Mason, Robert J; Searle, Karlee M; Bombard, Yvonne; Rahmadian, Amanda; Chambers, Alexandra; Mai, Helen; Morrison, Marjorie; Chan, Kelvin K W; Jerzak, Katarzyna J.
  • Mason RJ; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Searle KM; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Bombard Y; Li Ka Shing Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
  • Rahmadian A; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Chambers A; Pan-Canadian Oncology Drug Review, Canadian Agency for Drugs and Technologies in Health, Toronto, Ontario, Canada.
  • Mai H; Pan-Canadian Oncology Drug Review, Canadian Agency for Drugs and Technologies in Health, Toronto, Ontario, Canada.
  • Morrison M; Canadian Cancer Action Network, Toronto, Ontario, Canada.
  • Chan KKW; The Canadian Centre for Applied Research in Cancer Control, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Jerzak KJ; Odette Cancer Centre, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, Ontario, Canada.
Int J Technol Assess Health Care ; 36(3): 217-223, 2020 Jun.
Article en En | MEDLINE | ID: mdl-32383420
ABSTRACT

OBJECTIVES:

While involving patients in health technology assessment (HTA) has become increasingly common and important around the world, little is known about the optimal methods of evaluating patients' involvement (PI) in HTA. This scoping review was undertaken to provide an overview of currently available methods for the evaluation of PI, specifically the impact of PI on HTA recommendations.

METHODS:

A literature search was conducted using nine databases as well as a grey literature search of the websites of 26 organizations related to the conduct, practice or research of HTA to identify articles, reports and abstracts related to the evaluation of PI impact in HTA.

RESULTS:

We identified 1,248 unique citations, six of which met our eligibility criteria. These six records (five articles, and one report) were all published after 2012. Four assessed the impact of patient experience submissions on final HTA recommendations; one evaluated the impact of direct involvement on HTA committees, and one assessed impact of multiple forms of involvement. Methods of evaluation included quantitative analyses of reimbursement decisions, qualitative interviews with those directly involved in an assessment, surveys of patient groups and committee members, and the review of HTA reports.

CONCLUSIONS:

Quantitative evaluation of PI based on associations with funding decisions may not be feasible or fully capture the relevant impact of PI in the assessment of health technologies. Rather, a combination of both qualitative and quantitative strategies may allow for the most comprehensive assessment of the impact of PI on HTA recommendations when possible.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Participación del Paciente / Evaluación de la Tecnología Biomédica Tipo de estudio: Guideline / Health_technology_assessment / Prognostic_studies / Qualitative_research / Systematic_reviews Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Participación del Paciente / Evaluación de la Tecnología Biomédica Tipo de estudio: Guideline / Health_technology_assessment / Prognostic_studies / Qualitative_research / Systematic_reviews Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article